Linden Advisors’s NuVasive, Inc. NUVA Stock Holding History

Linden Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-41,700	Closed	-$2.32M	–	330
2020 Q2	$2.32M	Buy	+41,700	New	+$2.41M	0.04%	151

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Linden Advisors's NUVA Position: Q3 2020 in Review

Linden Advisors sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 41,700 shares — an estimated $2.32M sold.

Linden Advisors first reported a position in NUVA in Q2 2020 and held it in 1 quarter. The position peaked at $2.32M in Q2 2020. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

Linden Advisors reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
Linden Advisors sold 41,700 NuVasive, Inc. shares in Q3 2020, an estimated $2.32M.
Linden Advisors first reported a position in NuVasive, Inc. in Q2 2020 and held it in 1 quarter.
Linden Advisors's NuVasive, Inc. position peaked at $2.32M in Q2 2020.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Linden Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.